Report post
"Discover the latest in cancer immunotherapy with BI 765063, a SIRPα antagonist, and CD47-blocking agents. Learn about their mechanisms of action and how they're revolutionizing treatment for hematologic malignancies. Join Ose Immunotherapeutics' R&D Day on October 12th to watch video 2.7 and delve into the world of apoptosis and immune checkpoint inhibitors."

The World's Leading Crypto Trading Platform

Get my welcome gifts